Schedule 13D ownership disclosure
BIOMX INC
Common Stock, par value $0.0001 per share · CUSIP: 09090D103
Event date: 2025-02-27
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Deerfield Private Design Fund V, L.P.Reported CIK 0001815437
Shares: 7,779,222.00 · Class: 9.99%
- Deerfield Mgmt V, L.P.Reported CIK 0001876688
Shares: 7,779,222.00 · Class: 9.99%
- Deerfield Healthcare Innovations Fund II, L.P.Reported CIK 0001780064
Shares: 7,779,222.00 · Class: 9.99%
- Deerfield Mgmt HIF II, L.P.Reported CIK 0001665736
Shares: 7,779,222.00 · Class: 9.99%
- Deerfield Management Company, L.P.Reported CIK 0001009258
Shares: 15,558,445.00 · Class: 9.99%
- James E. FlynnReported CIK 0001352546
Shares: 15,558,445.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-25-000259
- Form type
- SCHEDULE 13D/A
- Filer
- BiomX Inc.
- CIK
- CIK 1739174
- Filed
- Mar 03, 2025
- Reporting period
- Feb 27, 2025
- Description
- Schedule 13D beneficial ownership